Biotech

All Articles

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Rehabs and a preclinical invulnerable...

Ventyx's last hope for inflamed med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medication carried out not help clients achieve remission in ...

Cognition's stage 2 SHINE records stain Alzheimer's prospect

.Cognition Rehabs' period 2 luster test has actually taken several of the appeal off the Alzheimer's...

BMS axes bispecific months after filing to work stage 3 test

.Bristol Myers Squibb has possessed a whiplash change of heart on its BCMA bispecific T-cell engager...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapeutics' $ 5.8 billion sale to Bristol Myer...

Asarina to close after initiatives to companion Tourette's drug fall short

.After connecting to more than 200 companies to partner a Tourette syndrome therapy that showed the ...

Novartis pens $150M upfront bispecifics take care of Dren Biography

.Novartis has actually possessed some misfortune with bispecific antitoxins over the last, but judgi...

AstraZeneca plants an EGFR plant with Pinetree bargain worth $45M

.Pinetree Therapies will definitely help AstraZeneca plant some plants in its own pipe with a brand ...

GRO rounds up $60M series B to take gout pain therapy into facility

.GRO Biosciences has ended the full week along with an additional $60.3 million in the bank, which t...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and retir...